<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00791687</url>
  </required_header>
  <id_info>
    <org_study_id>PI08/0027</org_study_id>
    <nct_id>NCT00791687</nct_id>
  </id_info>
  <brief_title>Prenatal Corticosteroids and Antioxidants in Preterm Infants</brief_title>
  <acronym>RESOX</acronym>
  <official_title>Prenatal Corticosteroids Enhance the Antioxidant Defense System in Extremely Low Gestational Age Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion Para La Investigacion Hospital La Fe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Valencia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Carlos III Health Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion Para La Investigacion Hospital La Fe</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Premature infants are highly susceptible to oxidative stress because of the immaturity of&#xD;
      their antioxidant defense system. The use of prenatal glucocorticosteroids administered to&#xD;
      the mother improves respiratory function and overall outcome. The investigators hypothesize&#xD;
      that prenatal glucocorticosteroids favor the expression and competence of the antioxidant&#xD;
      defense system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational study recruiting extremely low gestational age neonates (&lt;28 weeks&#xD;
      gestation) whose mothers received or not full scheduled prenatal glucocorticosteroids.&#xD;
      Healthy term newly born infants acted as controls.&#xD;
&#xD;
      At birth cord blood were drawn for the following analytical determinations: reduced and&#xD;
      oxidized glutathione; malondialdehyde; superoxide dismutase; catalase; glutathione&#xD;
      peroxidase; glutathione reductase; glutathione s-transferase. In addition, first urine voided&#xD;
      was collected for ortho-tyrosine/phenylalanine and&#xD;
      8-hydroxy-2-oxo-deoxyguanosine/2-deoxyguanosine determination. Analytical data and clinical&#xD;
      outcomes are compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">January 2005</completion_date>
  <primary_completion_date type="Actual">January 2005</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of glutathione redox status in cord blood.</measure>
    <time_frame>at birth</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of antioxidant activity.</measure>
    <time_frame>at birth</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">57</enrollment>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>PRENATAL CORTICOSTEROIDS</arm_group_label>
    <description>Extremely low gestational age neonates (&lt;28 weeks gestation) whose mothers received full course of betamethasone before delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NON PRENATAL CORTICOSTEROIDS</arm_group_label>
    <description>Extremely low gestational age neonates (&lt;28 weeks gestation) whose mothers did not receive full course of betamethasone before delivery.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Extremely low gestational age neonates &lt; 28 weeks gestation whose mothers received or not&#xD;
        antenatal glucocorticosteroids.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Gestational age &lt;28 weeks&#xD;
&#xD;
          -  Registered used or not of prenatal glucocorticosteroids by the mother&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of pro-or-antioxidant drugs by the mother during gestation&#xD;
&#xD;
          -  Major congenital malformations&#xD;
&#xD;
          -  Prenatal inflammation (E.G.:chorioamnionitis)&#xD;
&#xD;
          -  Chromosomopathies&#xD;
&#xD;
          -  Uncertainty about gestational age&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MAXIMO VENTO, PHD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Valencian Agency of Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Neonatology; University Hospital La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Arima M, Kumai T, Asoh K, Takeba Y, Murano K, Goto K, Tsuzuki Y, Mizuno M, Kojima T, Kobayashi S, Koitabashi Y. Effects of antenatal dexamethasone on antioxidant enzymes and nitric oxide synthase in the rat lung. J Pharmacol Sci. 2008 Feb;106(2):242-8. Epub 2008 Feb 9.</citation>
    <PMID>18270477</PMID>
  </reference>
  <reference>
    <citation>Chandrasekar I, Eis A, Konduri GG. Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension. Pediatr Res. 2008 Jan;63(1):67-72.</citation>
    <PMID>18043518</PMID>
  </reference>
  <reference>
    <citation>Asikainen TM, White CW. Antioxidant defenses in the preterm lung: role for hypoxia-inducible factors in BPD? Toxicol Appl Pharmacol. 2005 Mar 1;203(2):177-88. Review.</citation>
    <PMID>15710178</PMID>
  </reference>
  <reference>
    <citation>Asikainen TM, White CW. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal. 2004 Feb;6(1):155-67. Review.</citation>
    <PMID>14713347</PMID>
  </reference>
  <verification_date>November 2008</verification_date>
  <study_first_submitted>November 13, 2008</study_first_submitted>
  <study_first_submitted_qc>November 13, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2008</study_first_posted>
  <last_update_submitted>November 13, 2008</last_update_submitted>
  <last_update_submitted_qc>November 13, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2008</last_update_posted>
  <responsible_party>
    <name_title>Maximo Vento</name_title>
    <organization>Valencian Agency for Health</organization>
  </responsible_party>
  <keyword>Antioxidant enzymes</keyword>
  <keyword>Glutathione</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Prematurity</keyword>
  <keyword>Respiratory distress</keyword>
  <keyword>Non enzymatic antioxidant defense system</keyword>
  <keyword>Enzymatic antioxidant defense system</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

